ArticleJournal of orthopaedics2025
Revision for initial periprosthetic femur fracture increases likelihood of subsequent fracture in total hip arthroplasty.
Article in Journal of orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although a rare complication, periprosthetic fractures (PPF) following total hip arthroplasty (THA) are becoming more common. Revision THA (rTHA) for PPF is associated with high failure rates, and there is a paucity of literature reporting how often there is a subsequent PPF in these patients. This study aimed to determine the rate of femoral re-fracture following rTHA in patients with an initial PPF after primary THA. Methods: The retrospective study identified 2044 patients who underwent rTHA between 2017 and 2023. Propensity score-matched cohort analysis was conducted to control for demographic variables. The primary outcome was the re-fracture rate and survivability of those patients who were revised for PPF. Results: There were 183 patients who sustained an initial PPF and underwent subsequent rTHA. Of these patients, five (2.7 %) sustained re-fracture of the femur. After matching, there was a 3.7 % re-fracture rate in patients revised for an initial PPF compared to those who were not revised for PPF (0.37 %, Conclusion: Patients who were revised for an initial PPF had nearly a 10 times increased risk of re-fracturing compared to patients revised for other indications in THA. However, the similar readmission and failure rates and 1-year implant survivorship suggest comparable outcomes. Further analysis with a larger cohort and more outcome events is necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.